Creative Medical Technology Holdings is a biotechnology company based in Phoenix, Arizona, specializing in adult stem cell treatments for conditions in immunology, urology, neurology, and orthopedics. Established in 2009, it offers various products, including AlloStem and ImmCelz, and operates through its subsidiary, Creative Medical Technologies.
Creative Medical Technology Holdings (CELZ) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Creative Medical Technology Holdings's actual EPS was -$0.83, missing the estimate of -$0.53 per share, resulting in a -56.49% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
